3 completed, 1 withdrawn. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Kisspeptins: new trials by email Literature Review of Kisspeptins trials Research Report on Kisspeptins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Kissing as a Protective Factor Against Acidic pH in Saliva Kiss - Dental Caries, Tooth Demineralization | Not applicable | Completed | Universidad Catolica Santiago de Guayaquil | 33 | 2024-07-30 | 2026-04-24 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test Oral Glucose Tolerance Test, Kisspeptin, Placebo - Metabolic Diseases | Phase 1 | Completed | Massachusetts General Hospital | 16 | 2021-10-28 | 2026-03-06 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance Kisspeptin-10, mixed meal tolerance test - Insulin, Glucose | Phase 1 | Withdrawn | Stephanie B. Seminara, MD | 2019-09-01 | 2024-08-01 | |
| The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment Kisspeptin 1.6nmol/kg, Kisspeptin 3.2nmol/kg, Kisspeptin 6.4nmol/kg - Infertility | Phase 2 | Completed | Imperial College London | 175 | 2012-06-01 | 2021-06-08 |
Dental Caries (1) · Infertility (1) · Insulin Resistance (1) · Metabolic Diseases (1) · Tooth Demineralization (1)
Imperial College London (1) · Massachusetts General Hospital (1) · Stephanie B. Seminara, MD (1) · Universidad Catolica Santiago de Guayaquil (1)
United States (2) · Ecuador (1) · United Kingdom (1)
Margaret Lippincott, MD (2) · Waljit S Dhillo, PhD (1)
PMID 25036713, PMID 26192876, PMID 28854728, PMID 29206944, PMID 29446481, PMID 40674724
K23HD097296 (1)